Borel I M, Freire S M, Rivera E, Canellada A, Binaghi R A, Margni R A
IDEHU-Instituto de Estudios de la Immunidad Humoral (CONICET-UBA): Departamento de Microbiología Immunología y Biotecnología, Facultad de Farmacia y Bioquímica de la Universidad de Buenos Aires, Argentina.
Scand J Immunol. 1999 Mar;49(3):244-50. doi: 10.1046/j.1365-3083.1999.00484.x.
Rat spleen and peripheral blood lymphocytes express progesterone receptors whose concentration is increased greatly during the early phase of pregnancy. After stimulation of progesterone the expression of receptors was augmented 2-3 times. When cells were cultured in the presence of progesterone they released a soluble factor that inhibited cellular immunoreactions (MLR, CRC) and cellular proliferation as measured by thymidine incorporation by spleen-cell culture. This factor also inhibited the synthesis of anti-DNP antibodies by a mouse hybridoma and diminished the proportion of cells in phase S. However, the percentage of asymmetric molecules produced by the hybridoma remained unaltered. These results support the hypothesis that soluble factors released by rat lymphocytes modulate the immune response of the mother and participate in the mechanism that protects the fetus against antipaternal antibodies.
大鼠脾脏和外周血淋巴细胞表达孕激素受体,其浓度在妊娠早期大幅增加。孕激素刺激后,受体表达增加2 - 3倍。当细胞在孕激素存在的情况下培养时,它们释放出一种可溶性因子,该因子可抑制细胞免疫反应(混合淋巴细胞反应、细胞毒性反应)以及细胞增殖,增殖通过脾细胞培养中胸腺嘧啶核苷掺入法来测定。该因子还抑制小鼠杂交瘤产生抗二硝基苯酚抗体,并减少处于S期的细胞比例。然而,杂交瘤产生的不对称分子的百分比保持不变。这些结果支持了这样一种假说,即大鼠淋巴细胞释放的可溶性因子调节母体的免疫反应,并参与保护胎儿免受抗父系抗体影响的机制。